These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation. Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602 [TBL] [Abstract][Full Text] [Related]
6. New protein steals the show as 'costimulator' of T cells. Cohen J Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360 [No Abstract] [Full Text] [Related]
7. Inhibition of human anti-pig T cell response by anti-CD2, anti-CD40L, and CTLA4-Ig: a comparative study. Xu Y; Ryan D; Wu C; Bazin H; Latinne D; White-Scharf ME; Thall AD Transplant Proc; 2000 Aug; 32(5):926. PubMed ID: 10936275 [No Abstract] [Full Text] [Related]
11. T-cell stimulation: an abundance of B7s. Abbas AK; Sharpe AH Nat Med; 1999 Dec; 5(12):1345-6. PubMed ID: 10581066 [No Abstract] [Full Text] [Related]
12. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile. Broeren CP; Gray GS; Carreno BM; June CH J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816 [TBL] [Abstract][Full Text] [Related]
13. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409 [TBL] [Abstract][Full Text] [Related]
14. CD28/CTLA-4 and CD80/CD86 families: signaling and function. Slavik JM; Hutchcroft JE; Bierer BE Immunol Res; 1999; 19(1):1-24. PubMed ID: 10374692 [TBL] [Abstract][Full Text] [Related]
15. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116 [TBL] [Abstract][Full Text] [Related]
16. An engineered bifunctional recombinant molecule that regulates humoral and cellular effector functions of the immune system. Pizzolato MC; Fodor WL Transplantation; 2003 Feb; 75(4):542-9. PubMed ID: 12605124 [TBL] [Abstract][Full Text] [Related]
17. Carcinogen-modified dendritic cells induce immunosuppression by incomplete T-cell activation resulting from impaired antigen uptake and reduced CD86 expression. Woods GM; Doherty KV; Malley RC; Rist MJ; Muller HK Immunology; 2000 Jan; 99(1):16-22. PubMed ID: 10651936 [TBL] [Abstract][Full Text] [Related]
18. CD28-independent costimulation of T cells in alloimmune responses. Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642 [TBL] [Abstract][Full Text] [Related]
19. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand. Prud'homme GJ; Chang Y; Li X Hum Gene Ther; 2002 Feb; 13(3):395-406. PubMed ID: 11860706 [TBL] [Abstract][Full Text] [Related]
20. Treatment of autoimmunity by inhibition of T cell costimulation. Daikh DI; Wofsy D Adv Exp Med Biol; 2001; 490():113-7. PubMed ID: 11505969 [No Abstract] [Full Text] [Related] [Next] [New Search]